Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol., 27 August 2025

Sec. Reproduction

Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1642197

Exploration of the active components and mechanisms of Epimedium for the treatment of Undescended Testis

Zhonglei Deng&#x;Zhonglei Deng1†Sirui Zhang&#x;Sirui Zhang2†Haiyang ZhaoHaiyang Zhao3Shijia XuShijia Xu2Miao QiMiao Qi4Tianle PuTianle Pu5Hui Wang*Hui Wang2*
  • 1Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
  • 2State Key Laboratory of Reproductive Medicine and Offspring Health, Department of Histology and Embryology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China
  • 3Chinese Medicine Research Institute, Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, China
  • 4The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China
  • 5The Second School of Clinical Medicine, Nanjing Medical University, Nanjing, China

Background: Undescended Testis, the most common congenital male reproductive disorder in children, demonstrates complex pathogenesis with genetic predisposition. While early surgical intervention (before 18 months) remains standard care, pharmacological options are limited.

Purpose: Explore the therapeutic potential of Traditional Chinese Medicine for Undescended Testis.

Study design: This study employs multiple bioinformatics approaches to search for potential Traditional Chinese Medicines for Undescended Testis treatment and investigate their therapeutic mechanisms.

Methods: This study integrated medication regularity analysis, network pharmacology, Mendelian randomization, and molecular docking, with exploration conducted through cellular and animal models.

Results: Our analysis identified 27 bioactive Epimedium compounds, with Quercetin, Kaempferol, and Icariin showing particular promise. Protein interaction networks revealed AKT1, PARP1, and PGR as key targets. Functional enrichment analysis primarily focused on biological processes including response to stress-induced damage (such as reactive oxygen species, chemical toxins, and other stressors), steroid signaling and receptor activation, transmembrane signal transduction, as well as cellular proliferation and apoptosis regulation. Molecular docking demonstrated Yinyanghuo B’s strong binding affinity with PARP1 (-7.2 kcal/mol). Mendelian randomization confirmed PARP1 reduction’s causal relationship with lower Undescended Testis risk. We constructed animal and cellular heat stress models to simulate Undescended Testis, and subsequent experiments observed significant DNA damage. Thermally stressed TM4 cells showed significant PARP1 upregulation, suggesting its critical role in testicular heat stress response by accelerating DNA damage repair.

Conclusion: These findings potentially provide mechanistic evidence supporting Epimedium’s traditional use while advancing Traditional Chinese Medicine modernization through contemporary pharmacological validation.

1 Introduction

Undescended Testis is a common congenital disorder in which the testes fail to descend into the scrotum at birth, affecting the reproductive health of male infants (1). Epidemiological studies have shown that the incidence of congenital Undescended Testis ranges from 1% to 9% (2, 3). The condition demonstrates progressive histopathological deterioration: interstitial fibrosis emerges by age 1, followed by germ cell depletion and peritubular fibrosis at age 2, with subsequent mitochondrial degeneration and collagen accumulation in older children (4). Beyond impaired spermatogenesis (manifesting as oligoasthenoteratospermia), long-term sequelae include reduced fertility, increased risk of testicular cancer, and psychological impacts due to appearance (5).

Sustained exposure of the testes to suprascrotal temperatures is widely recognized as a key pathological mechanism in Undescended Testis, inducing chronic heat stress (6). Research indicates that this persistent chronic heat stress impairs male reproductive health by disrupting the spermatogenic microenvironment. Key mechanisms include damage to Sertoli cell structure and function and compromised integrity of the blood-testis barrier (7). In experimental research, the acute heat stress model is widely used to study early testicular heat stress responses, as it shares some core mechanisms with chronic heat stress (8).

The etiology of Undescended Testis involves multifactorial interactions, with emerging evidence highlighting environmental influences alongside hormonal and genetic factors (9). Surgical intervention via orchiopexy before 18 months remains the gold standard, preventing testicular dysgenesis and preserving fertility (10). However, surgical limitations persist for complex cases, accompanied by inherent procedural risks. Endocrine therapies using human chorionic gonadotropin or gonadotropin-releasing hormone (hCG/GnRH) demonstrate efficacy in boosting germ cell counts (11, 12), yet histopathological analyses reveal transient adverse effects. These include elevated intratesticular pressure, testicular congestion, and germ cell apoptosis (13). Therefore, it is crucial to seek more effective and safer pharmacological treatments or adjuvant strategies.

Traditional Chinese Medicine (TCM) posits that the fundamental pathogenesis of male infertility is the deficiency of kidney essence, with the kidney being the “foundation of reproduction,” directly influencing reproductive function (14). Traditional Chinese Medicine offers novel therapeutic perspectives through its holistic approach. For example, Semen Cuscutae-Fructus Lycii ameliorates spermatogenic dysfunction by suppressing oxidative stress-induced ferroptosis through the Nrf2/HO-1 signaling pathway (15); Ginsenoside Rg1 upregulates expression levels of Cx43/p-PI3K/mTOR, mitigating testicular aging (16); Icariin, derived from Epimedium, enhances testosterone biosynthesis by upregulating steroidogenic enzyme activity and ameliorates testicular dysfunction in mice (17); In vitro studies have also found that Icariin can promote the proliferation of Sertoli cells and improve the spermatogenic microenvironment by regulating the ERK1/2 pathway (18). The spermatogenic microenvironment, particularly Sertoli cells, plays a critical role in both the development and prevention of Undescended Testis, making the identification of protective components essential. Leydig cells are also essential for testicular descent via secretion of testosterone and insulin-like peptide 3(INSL3). INSL3 promotes gubernacular swelling and cord shortening, while testosterone drives the inguinoscrotal phase (19, 20). In cryptorchidism, oxidative stress impairs Leydig cell function, reducing testosterone. Rubus apetalus enhances reproductive function by boosting testosterone synthesis (21). While traditional Chinese herbs such as Epimedium, licorice, and Poria cocos show potential as therapeutic options, their specific molecular targets and regulatory pathways remain undefined.

Contemporary methodologies enable systematic exploration of TCM mechanisms: Medication regularity analysis is a process of systematically sorting out and mining drug use data (such as prescription, drug use record, therapeutic effect feedback, etc.) to find the common characteristics and potential laws of drug use. Network pharmacology identifies polypharmacological targets through protein interaction mapping. Mendelian randomization establishes causal relationships using genetic instrumental variables. Molecular docking predicts ligand-receptor binding affinities with <2Å resolution. In vitro and in vivo models validate the theoretical results.

This study aims to identify key TCMs for treating Undescended Testis through medication regularity analysis and network pharmacology, exploring their material basis to offer new insights and theoretical evidence. By integrating methods like Mendelian randomization, molecular docking, and in cell and animal experiments, we seek to elucidate potential mechanisms and provide feasible treatment suggestions, advancing the modern and precise application of TCM.

2 Materials and methods

2.1 Medication regularity analysis of Undescended Testis

Using databases such as CNKI, VIP, Wanfang Data, Web of Science, Elsevier ScienceDirect, SpringerLink, and NCBI, we initially used the search expression [“Undescended Testis” AND “medication regularity analysis”] and found no relevant articles. We then modified the search expression to [“oligospermia” AND “medication regularity analysis”] OR [“asthenospermia” AND “medication regularity analysis”] OR [“teratospermia” AND “medication regularity analysis”]. A total of 18 relevant articles were included, and the frequency of drug use reported in these studies were statistically analyzed. The top twenty drugs by usage frequency are shown in Table 1.

Table 1
www.frontiersin.org

Table 1. Medication regularity analysis of sperm disorders (OAT).

2.2 Network pharmacology analysis

2.2.1 Identification of active components and targets of Epimedium

We searched the TCMSP (https://old.tcmsp-e.com/tcmsp.php) database for the chemical components of Epimedium, setting the screening criteria as oral bioavailability (OB) ≥ 30% and drug-likeness (DL) ≥ 0.18, and combined with the 2020 edition of the Chinese Pharmacopoeia to manually screen out the active components of Epimedium (Icariin, Epimedin A, Epimedin B and Epimedin C), summarizing the effective components of Epimedium. We used the TCMSP and SwissTargetPrediction (http://swisstargetprediction.ch/) databases to search for and predict the targets of the active components, and corrected the gene names of the active component targets using the UniProt database, removing duplicate targets.

2.2.2 Identification of targets related to Undescended Testis

Using the Genecards (https://www.genecards.org/) database, we searched for targets related to Undescended Testis, removing duplicates. We used the R package “VennDiagram” to obtain the intersection targets of the active components of Epimedium and Undescended Testis, and drew a Venn diagram.

2.2.3 Construction of Protein-Protein Interaction network and screening of key targets

We performed PPI analysis on the intersection targets obtained in 2.2 using the STRING (https://cn.string-db.org/) database, with the species set to “Homo sapiens” and the minimum interaction score set to 0.4, hiding unrelated proteins.

2.2.4 Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis

Using the R packages “enrichplot” and “ggplot2”, we performed GO and KEGG functional enrichment analysis on the intersecting targets. GO enrichment analysis included biological processes (BP), cellular components (CC), and molecular functions (MF). We selected the top 10 items according to ascending P-values (i.e., most significant) and drew charts for GO and KEGG.

2.3 Mendelian randomization analysis

2.3.1 Tool variable acquisition and screening

The intersection targets of Epimedium and Undescended Testis were used as exposure variables. We used cis-pQTL summary data from the deCODE (22) and UK Biobank Pharma Proteomics Project (UKB-PPP) (https://registry.opendata.aws/ukbppp/) projects as exposure variables, screening with criteria of P<1e-6, r2<0.01, and clump processing with kb=5000. The outcome variable (Undescended Testis) was derived from the FinnGen Documentation of R12 release.

2.3.2 Mendelian randomization analysis and secondary validation

We performed two-sample Mendelian randomization (MR) analysis based on the R package “TwoSampleMR”. We assessed the causal relationship between the intersection targets and Undescended Testis using causal effect estimation methods including inverse variance weighted (IVW), MR-Egger regression, simple mode, weighted median, and weighted mode. P<0.05 was considered statistically significant.

For targets with significant causal relationships with Undescended Testis (P<0.05), we performed secondary validation. Using publicly available data from GTEx v8 (https://www.gtexportal.org/), we obtained cis-eQTLs related to the targets across 49 human tissues and used these cis-eQTLs as instrumental variables for two-sample MR analysis. The assessment methods included inverse variance weighted (IVW), MR-Egger regression, simple mode, weighted median, and weighted mode. Odds ratios (OR) and their 95% confidence intervals (95%CIs) were estimated, and a p-value < 0.05 was considered statistically significant.

2.4 Molecular docking

We conducted molecular docking to analyze causal targets from MR analysis and active components of Epimedium. Molecular docking predicts protein-ligand binding modes and interaction strengths by identifying optimal conformations with minimal binding free energy.

Protein Preparation: 3D protein structures from the PDB database were imported into AutoDock4. Water molecules were removed, hydrogen atoms were added, and files were converted to PDBQT format.

Ligand Preparation: Compound 3D structures from PubChem were similarly processed in AutoDock4, with torsion trees configured automatically before exporting to PDBQT format.

Docking & Visualization: Receptor and ligand PDBQT files were docked in AutoDock4 using a protein-centered grid box to ensure full coverage. The lowest-energy conformation was selected and visualized using PyMol 2.5.

2.5 In vitro model validation

2.5.1 Cell culture

Normal mouse testicular Sertoli cells (TM4, CL-0456) and complete medium (CM-0456) were purchased from Nanjing Wingfleas Biotechnology Co., Ltd. (Nanjing, China). Under conventional conditions, cells were cultured at 37°C with 5% CO2.

2.5.2 Model construction

Cells without any treatment were used as the blank group; TM4 cells with 80% confluence were treated with 42°C warm water bath for 20 minutes to simulate the heat stress environment of Undescended Testis, serving as the Undescended Testis model group (8, 23, 24).

2.5.3 qPCR

RNA was extracted using an RNA extraction kit (G3640) purchased from Wuhan Seaweed Biotechnology Co., Ltd. (Wuhan, China); RNA was reverse-transcribed into cDNA using a reverse transcription kit (R223-01) purchased from Nanjing Novozyme Biotechnology Co., Ltd. (Nanjing, China); SYBR Green Premix (11201ES08) was added to the amplification system along with the template, primers, and SYBR Green Premix for real-time quantitative PCR to measure the mRNA expression levels of GAPDH, STAT1, RASA1, PGR, IGFBP3, PARP1, and CALCA. The SYBR Green Premix was purchased from Yeasen Biotechnology Co., Ltd. The qPCR instrument (A28575) was purchased from Thermo Fisher Scientific (MA, USA).

RNA was extracted using an RNA extraction kit (G3640, Wuhan Seaweed Biotechnology). cDNA was synthesized from RNA using a reverse transcription kit (R223-01, Nanjing Novozyme Biotechnology). For qPCR, the amplification system included SYBR Green Premix (11201ES08, Yeasen Biotechnology), template, and primers to measure mRNA expression of…

The primers used in this experiment were as follows:

GAPDH:

5’-TCGGATCAACGGATTTGGT-3’ (forward);

5’-TTCCCGTTCTCAGCCTTGAC-3’ (reverse);

STAT1:

5’- GCTGCCTATGATGTCTCGTTT-3’ (forward);

5’- TGCTTTTCCGTATGTTGTGCT-3’ (reverse);

RASA1:

5’- GGCCCTCAGATAATACTCCTGG-3’ (forward);

5’- GCGGCCTCCCATCATAAACT-3’ (reverse);

PGR:

5’- CCAGACGGAAAGACAGGGG-3’ (forward);

5’- CCTTCCCTATGAGTGGCTTCT-3’ (reverse);

IGFBP3:

5’- TCTAAGCGGGAGACAGAATACG-3’ (forward);

5’- CTCTGGGACTCAGCACATTGA-3’ (reverse);

PARP1:

5’- GCTTTATCGAGTGGAGTACGC-3’ (forward);

5’- GGAGGGAGTCCTTGGGAATAC-3’ (reverse);

CALCA:

5’- GAGGGCTCTAGCTTGGACAG-3’ (forward);

5’- AAGGTGTGAAACTTGTTGAGGT-3’ (reverse).

The primers were purchased from GenScript Biotechnology Co., Ltd. (NJ, USA).

2.5.4 TUNEL staining

Cells grown on coverslips were washed three times with PBS and fixed with pre-chilled immunostaining fixative for 20 minutes. After three additional washes with PBS, the cells were permeabilized with 0.1% Triton X-100 for 5 minutes. Then, 100 µL of 1× Equilibration Buffer was added and equilibrated at 25°C for 20 minutes, followed by the addition of 50 µL of TdT and incubation at 25°C for 60 minutes. The cells were mounted with DAPI and observed under a fluorescence microscope after 2 hours. The TUNEL assay kit (A113) was purchased from Nanjing Novizan Biotechnology Co., Ltd.

2.5.5 Western blot

Treated cells were collected and lysed in 1× RIPA lysis buffer (P0013C) containing protease inhibitors to extract proteins. Protein concentration was determined using the BCA method (P0011). A total of 30 µg of protein samples were separated by 10% SDS-PAGE gel and transferred onto nitrocellulose membranes. The membranes were blocked with 5% skim milk at room temperature for 1 hour, followed by incubation with specific primary antibodies at 4°C overnight: HSP70 (66183-1-Ig) and GAPDH (60004-1-Ig). Subsequently, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (A0208) at room temperature for 1 hour. Target proteins were detected using ECL luminescent solution (FD8000), and immunoblot images were acquired and analyzed. The lysis buffer, BCA kit, and secondary antibodies were purchased from Beyotime Biotechnology (Shanghai, China); HSP70 and GAPDH antibodies were purchased from Wuhan Sanying Biotechnology (Wuhan, China).

2.6 In vivo model validation

2.6.1 Mouse feeding

All mice were raised in a specific pathogen-free environment. All animal protocols were approved by the Animal Care and Use Committee of Nanjing Medical University (IACUC-2402036). All mice were purchased from Jiangsu GemPharmatech Co., Ltd. (Nanjing, China). The animals were randomly divided into groups, with 5 mice per group.

2.6.2 Model construction

Nine-week-old male C57B6 wild-type mice were selected. Mice without any treatment served as the blank control group, while mice with testes subjected to a 42°C warm water bath for 20 minutes served as the model group.

2.6.3 Histopathological analysis

After fixation with 4% paraformaldehyde for 48 h, testicular tissues were subjected to gradient alcohol dehydration and paraffin embedding for histopathological evaluation. Subsequently, 5-μm sections were obtained and mounted on slides, followed by drying for subsequent usage. H&E staining (G1001, Servicebio) was employed to visualize the tissue sections. The vacuolation rate of seminiferous tubules was quantified and statistically analyzed using ImageJ software. Specifically, five non-consecutive sections were randomly selected from each mouse, and the number of seminiferous tubules with vacuolation was counted in each section. The number of total tubules and those showing vacuolation (including tubules containing only Sertoli cells or evident vacuoles) were counted. The vacuolation rate was calculated using the formula:(Number of Sertoli cell-only tubules + vacuolated tubules)/Total tubules*100%. The data were subjected to statistical analysis and presented in the form of a bar graph for further analysis.

2.6.4 TUNEL staining

Testes from treated mice were collected, fixed, and embedded in paraffin for sectioning. Paraffin sections were subjected to TUNEL staining. The sections were dewaxed in a 65°C oven for 2 hours, immersed in xylene twice at 37°C for 15 minutes each, and then incubated in absolute ethanol twice for 5 minutes each, followed by incubation in 90%, 80%, and 70% ethanol for 5 minutes each. The sections were rinsed with ddH2O for 10 minutes. They were then fixed with pre-chilled immunostaining fixative for 20 minutes. After washing three times, the sections were permeabilized with 0.1% Triton X-100 for 5 minutes. Next, 100 µL of 1×Equilibration Buffer was added and equilibrated at 25°C for 20 minutes, followed by the addition of 50 µL of TdT and incubation at 25°C for 60 minutes. The sections were mounted with DAPI and observed under a fluorescence microscope after 2 hours.

3 Results

Our study identified Epimedium as a key herb among Traditional Chinese Medicines used for treating sperm-related diseases, with 27 active components including Quercetin, Kaempferol, Icariin, and Yinyanghuo B (Table 2). Through network pharmacology analysis, we discovered 341 potential targets for Epimedium, 108 of which overlapped with 2561 known Undescended Testis-related targets (Figure 1A). Protein-protein interaction analysis (Figure 1A) revealed critical nodes such as AKT1, TP53, MAPK1, PRKACA, PARP1, and CTNNB1, while GO enrichment (Figure 1B) highlighted biological processes including oxidative stress response and tube diameter regulation. KEGG pathway analysis (Figure 1C) implicated key signaling mechanisms like the HIF-1 pathway and endocrine resistance.

Table 2
www.frontiersin.org

Table 2. Effective components of Epimedium.

Figure 1
Panel A shows a network graph with interconnected nodes labeled with gene names, along with a Venn diagram comparing UT and YYH. Panel B is a bar chart displaying Gene Ontology (GO) terms enrichment, categorized by biological process, cellular component, and molecular function. Panel C is a bubble chart illustrating KEGG pathway enrichment with pathways plotted against gene ratio, bubble size indicating count, and color representing p-value. Panel D depicts a 3D ribbon model of a protein structure with highlighted functional sites.

Figure 1. Network pharmacology figures. (A) Venn diagram, UT, Undescended Testis, YYH, Epimedium; PPI network diagram; (B) GO enrichment analysis; (C) Bubble chart of KEGG enrichment analysis; (D) Molecular docking diagram of Yinyanghuo B and PARP1.

Mendelian randomization analysis using pQTL data identified six proteins with significant associations (Figures 2, 3): IGFBP3 increased disease risk (OR=1.31, 95% CI: 1.04-1.67, P=0.023), while STAT1 (OR=0.16, 95% CI: 0.05-0.55, P=0.004), RASA1 (OR=0.58, 95% CI: 0.39-0.87, P=0.009), PGR (OR=0.14, 95% CI: 0.02-0.84, P=0.032), PARP1 (OR=0.37, 95% CI: 0.19-0.74, P=0.005), and CALCA (OR=0.53, 95% CI: 0.29-0.96, P=0.038) showed protective effects. Subsequent eQTL (Figure 4) analysis confirmed PARP1’s causal relationship in pancreatic tissue (OR=0.53, 95% CI: 0.28-0.99, P=0.048).

Figure 2
Forest plot showing genetic associations with undescended testes for genes STAT1, RASA1, PGR, and IGFBP3. Methods include MR Egger, Weighted Median, Inverse Variance Weighted, Simple Mode, and Weighted Mode. Each method shows nSNP, Beta, OR with 95% CI, and P-values. Confidence intervals are represented by horizontal lines, with some crossing the null value line at one, indicating varied significance levels.

Figure 2. Two-sample MR analysis of intersection targets pQTL (deCODE) and Undescended Testis. Gene, Target gene; nSNP, Number of effective SNPs (P<1e-6); OR, Odds Ratio; 95% CI, 95% Confidence Interval; P, p-value corresponding to SNPs in MR results.

Figure 3
Forest plot displaying odds ratios (OR) and 95% confidence intervals (CI) for genetic methods related to PARP1 and CALCA genes. For PARP1, the inverse variance weighted method shows significant association (OR 0.37, P = 0.005). For CALCA, significance is noted with inverse variance weighted (OR 0.53, P = 0.038). Horizontal lines denote confidence intervals, with dashed vertical line at OR = 1, representing no effect.

Figure 3. Two-sample MR analysis of intersection targets pQTL (UKB-PPP) and Undescended Testis. Gene, Target gene; nSNP, Number of effective SNPs (P<1e-6); OR, Odds Ratio; 95% CI, 95% Confidence Interval; P, p-value corresponding to SNPs in MR results.

Figure 4
Forest plot showing the odds ratio (OR) and confidence intervals (CI) for genetic associations across various tissues for genes PARP1, PGR, RASA1, and STAT1. Each row lists gene, tissue, method, nSNP, OR with 95% CI, and P-value. A significant association in the pancreas tissue for PARP1 is marked with a red asterisk, showing OR 0.53 (0.28 to 0.99) and P-value 0.048. Each line includes a point estimate with a horizontal line representing the CI, crossing or not crossing the null value line at OR = 1.

Figure 4. Validation MR analysis of positive genes eQTL and Undescended Testis. Gene, Target gene; Tissue, Tissue where SNPs are located; nSNP, Number of effective SNPs (P<1e-6); OR, Odds Ratio; 95% CI, 95% Confidence Interval; P, p-value corresponding to SNPs in MR results; an asterisk “*” denotes P<0.05 as a statistically significant result in the Mendelian randomization analysis.

Experiments validated heat stress (HS)-induced reproductive system damage using TM4 cells and mouse models (Figure 5A). The results of H&E staining in histology showed that there were obvious cavities in the seminiferous tubules in the heat stress group (HS) compared to the control group, with a significant decrease in the number of cells in the tubules. The seminiferous tubules with disrupted structure, obviously irregular arrangement, and sharply decreased Sertoli cells, presenting vacuolar changes were counted as vacuolar tubule numbers. The ratio of vacuolar tubule numbers to total tubule numbers was calculated (Figure 5B). Western blot analysis confirmed elevated HSP70 protein levels following HS treatment, demonstrating successful HS modeling (Figure 5C). qPCR analysis showed upregulated transcriptional activity of Stat1 and Parp1, and downregulated expression of Rasa1 (Figure 5D), aligning with bioinformatics predictions. TUNEL assays demonstrated significantly increased DNA damage in HS-treated TM4 cells and testicular tissues compared to the controls (Figure 5E), confirming HS-triggered DNA damage and apoptosis.

Figure 5
A: Diagram showing the experimental setup for heat stress (HS) on mice and cells, including RNA extraction and qPCR. B: Histology images showing villous structure changes in normal (NC) and heat-stressed (HS) samples with a bar graph indicating villous number increase in HS. C: Western blot showing increased HSP70 protein expression in HS samples compared to NC. D: Bar graph comparing mRNA levels of various genes between NC and HS samples, showing significant changes. E: Fluorescent images of cells and mouse tissue, with DAPI and TUNEL staining, highlighting DNA damage in HS samples indicated by arrows.

Figure 5. HS increased the apoptosis level of mouse testicular cells and changed the transcriptional activity of related genes. (A) Schematic representation of the in vitro (TM4 cell line) and in vivo (mouse) experimental models; (B) Results of H&E staining of mouse testes in each group; (C) HSP70 protein expression in the normal control (NC) and heat stress (HS) groups; (D) Transcriptional activity of related genes in the NC and HS groups; (E) Apoptosis levels in TM4 cells and testicular tissue sections of mice. *P<0.05, **P<0.01, compared with control.

We performed molecular docking between PARP1 and its corresponding Epimedium component, Yinyanghuo B, and the results showed a minimum binding energy of -7.2 kcal/mol (less than -7 kcal/mol), indicating a stable binding between PARP1 and Yinyanghuo B (Figure 1D).

4 Discussion

Undescended Testis, a complex congenital male reproductive disorder, presents limited therapeutic options and frequent complications, highlighting the need for novel adjunct treatments. Traditional Chinese Medicine has long utilized Epimedium for reproductive conditions. Animal studies (2527) demonstrate that its active components -Icariin and total flavonoids- alleviate testicular damage through anti-inflammatory and antioxidant mechanisms. Compounds found in Epimedium, such as Epimedium mixtures and β-sitosterol, enhance male reproductive function by modulating androgen levels, while Icariin, Quercetin, Kaempferol, and Luteolin improve the spermatogenic microenvironment. Total flavonoids and Icariin II (ICAII) promote spermatogenesis itself (24, 28, 29). Specifically, Icariin helps maintain blood-testis barrier (BTB) integrity by inhibiting the p38 MAPK/MMP9 signaling pathway, thereby increasing the expression of tight junction proteins like ZO-1, Occludin, and Claudin-11 (29). Furthermore, key Epimedium constituents Quercetin and Kaempferol boost Occludin expression in Sertoli cells, and Luteolin enhances the testicular microenvironment by activating the Nrf2 signaling pathway and upregulating the gap junction protein Connexin 43 (CX43) (30, 31). Additionally, in protecting spermatogenesis, total flavonoids, Icariin II and Icariside II reduce testicular oxidative stress damage and decrease germ cell apoptosis by enhancing antioxidant enzyme activity (24, 32, 33). These compounds show potential for mitigating blood-testis barrier disruption, enhancing testosterone production, and restoring spermatogenesis, providing pharmacological rationale for exploring Epimedium-derived therapies in Undescended Testis management.

Our findings identify Quercetin, Kaempferol, Icariin, Icariside II, Luteolin, and Yinyanghuo B as key active components of Epimedium. Quercetin modulates androgen receptor and TNF-α expression, suppresses oxidative stress and inflammation, and counteracts testicular dysfunction induced by lead acetate or aluminum oxide nanoparticles (34). Kaempferol enhances testicular weight, improves sperm quality (e.g., motility and morphology), and alleviates oxidative stress by reducing malondialdehyde while elevating glutathione levels, thereby potentially mitigating reproductive damage in male rats exposed to Echis ocellatus venom (35).

PPI network analysis highlights AKT1, TP53, IL6, TNF, ESR1, EGFR, PARP1, CASP3, and PGR as potential therapeutic targets. AKT1, critical for cell survival and apoptosis, regulates Sertoli cell development; its deficiency disrupts seminiferous tubule formation and accelerates germ cell death under stress (36). TP53, a tumor suppressor, inhibits DNMT1 and upregulates miR-199a/214 in testicular germ cell tumors (TGCT), impairing DNA methylation to exert anticancer effects (37). EGFR dysregulation (via mutation, amplification, or overexpression) correlates with elevated TGCT recurrence risk post-orchiectomy (38). These targets collectively underscore Epimedium’s multifaceted mechanisms in addressing Undescended Testis pathogenesis.

Functional enrichment analysis revealed that Epimedium targets biological processes linked to xenobiotic response, chemical stress adaptation, and oxidative stress mitigation, suggesting its role in modulating testicular recovery via environmental stress regulation. KEGG pathway analysis further identified key signaling cascades, including chemical carcinogenesis-receptor activation, endocrine resistance, AGE-RAGE, HHV-8 infection, and HIF-1 pathways. Epidemiological studies link prenatal endocrine-disrupting chemical exposure to Undescended Testis and impaired reproductive outcomes (39). The AGE-RAGE axis drives germ cell dysfunction by inducing oxidative stress and inflammation via AGE accumulation (40). Hypoxia and dihydrotestosterone deficiency in Undescended Testes disrupt Sertoli cell integrity, impairing spermatogenesis (41). Notably, HIF-1 pathway inhibition (e.g., by melatonin) alleviates hypoxia-induced Sertoli cell fibrosis (42). These findings highlight Epimedium’s multi-target potential in counteracting disease-related hypoxia, oxidative stress, and inflammatory pathways, supporting its therapeutic utility in Undescended Testis management.

Cells face constant exposure to DNA-damaging stressors, with unrepaired genomic lesions contributing to diseases like cancer (43). PARP1, the founding member of its family (44), plays critical roles in DNA repair by catalyzing poly (ADP-ribose) (PAR) polymer synthesis at damage sites through PARylation. This post-translational modification facilitates multiple repair pathways, including base excision repair and strand break resolution. Undescended Testis elevates testicular temperature, inducing oxidative stress and cellular damage linked to male infertility and germ cell tumors (45). Two-sample Mendelian randomization analysis results showed a significant causal relationship between elevated PARP1 levels and reduced risk of Undescended Testis. Heat exposure disrupts Sertoli cell function, compromises the blood-testis barrier, and triggers germ cell apoptosis (26, 45). In this study, we subjected the Sertoli cell line (TM4 cell line) to heat stress to simulate the pathological microenvironment of Undescended Testis. PCR experimental results showed that compared with the blank group, the levels of Parp1 in TM4 cells subjected to heat stress were significantly increased, indicating that Parp1 plays a key role in the repair of heat stress damage. Molecular docking demonstrated strong binding between PARP1 and Yinyanghuo B (binding energy -7.2 kcal/mol), indicating potential therapeutic modulation of PARP1 pathways.

Recent investigations have demonstrated that heat stress (HS)-induced tissue repair involves dynamic ubiquitination modulation, suggesting that the ubiquitination-dependent clearance of misfolded proteins may represent a pivotal mechanism for managing HS-related pathologies and Undescended Testis rehabilitation. Notably, our functional enrichment analysis failed to reveal significant associations with ubiquitination-related processes, potentially attributable to the predominant focus of the analyzed datasets on early-phase Undescended Testis pathogenesis mechanisms, with limited inclusion of contemporary findings regarding reversible testicular damage repair. Future work should expand cohorts, diversify data sources, and employ rigorous designs. Furthermore, while the in vitro and in vivo heat stress models used in this study simulate the injury mechanisms of Undescended Testis to some extent, they may not fully capture the complexity of human clinical Undescended Testis. While acute and chronic heat stress share fundamental pathophysiological mechanisms, Undescended Testis as a chronic heat stress condition involves multifaceted interactions of hormonal regulation, genetic predisposition, and environmental factors. The duration, severity of cumulative damage, and tissue adaptive responses cannot be fully replicated. Therefore, translating findings from acute heat stress models to clinical Undescended Testis requires additional validation through chronic heat stress studies and clinical investigations. It should be noted that this study primarily focused on predicting potential therapeutic targets for heat stress intervention through Mendelian randomization analysis, therefore employing only acute heat stress models for preliminary exploration. Secondly, our data were derived exclusively from European populations, limiting diversity in terms of ancestry, environment, and geographical region. Additionally, the Mendelian randomization analysis based on GWAS could be susceptible to confounding by other genetic or environmental factors, which were not fully accounted for in the analysis. Future work should expand cohorts, diversify data sources, and employ rigorous designs. In addition, combining animal model studies and multicenter clinical trials will help validate the findings and promote clinical applications.

The results of this study suggest that Epimedium and its active components may hold promise as adjunctive therapies for Undescended Testis, particularly Yinyanghuo B, which targets key proteins such as PARP1 to enhance testicular function. Future research should further investigate the clinical application of Epimedium in patients with Undescended Testis, with the aim of fostering the integration of Traditional Chinese Medicine and modern medical practices, thereby offering novel insights and therapeutic approaches for the treatment of male infertility.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.

Ethics statement

The animal study was approved by Institutional Animal Care and Use Committee of Nanjing Medical University. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

ZD: Formal analysis, Writing – original draft. SZ: Writing – original draft, Formal analysis. HZ: Writing – original draft, Data curation, Formal analysis. SX: Formal analysis, Writing – original draft, Data curation. MQ: Writing – original draft, Data curation. TP: Writing – original draft, Data curation. HW: Writing – review & editing, Funding acquisition, Conceptualization.

Funding

The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the National Natural Science Foundation of China to Hui Wang (no. 82374225).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

TCM, Traditional Chinese Medicine; OB, Oral Bioavailability; DL, Drug-likeness; PPI, Protein-Protein Interaction; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; BP, Biological Processes; CC, Cellular Components; MF, Molecular Functions; UKB-PPP, UK Biobank Pharma Proteomics Project; MR, Mendelian randomization; IVW, Inverse Variance Weighted; HS, Heat Stress; PAR, poly (ADP-ribose).

References

1. Li W, Chen Z, Xu W, Gao Y, Liu Z, Li Q, et al. Prevalence of congenital cryptorchidism in China: a nationwide population-based surveillance study 2007–2021. Andrology. (2025) 13:577–86. doi: 10.1111/andr.13686

PubMed Abstract | Crossref Full Text | Google Scholar

2. Kübarsepp V, Varik K, Varendi H, Antson A, Veinla M, Nellis G, et al. Prevalence of congenital cryptorchidism in estonia. Andrology (2022) 10(2):303–9.

Google Scholar

3. Wang X, Liu Q, Zhuang Z, Cheng J, Zhang W, Jiang Q, et al. Decoding the pathogenesis of spermatogenic failure in cryptorchidism through single-cell transcriptomic profiling. Cell Rep Med. (2024) 5:101709. doi: 10.1016/j.xcrm.2024.101709

PubMed Abstract | Crossref Full Text | Google Scholar

4. Elder JS. The Undescended Testis: hormonal and surgical management. Surg Clin North Am. (1988) 68:983–1005. doi: 10.1016/s0039-6109(16)44633-5

PubMed Abstract | Crossref Full Text | Google Scholar

5. Florou M, Tsilidis KK, Siomou E, Koletsa T, Syrnioti A, Spyridakis I, et al. Orchidopexy for congenital cryptorchidism in childhood and adolescence and testicular cancer in adults: an updated systematic review and meta-analysis of observational studies. Eur J Pediatr. (2023) 182:2499–507. doi: 10.1007/s00431-023-04947-9

PubMed Abstract | Crossref Full Text | Google Scholar

6. Gao Y, Wang C, Wang K, He C, Hu K, and Liang M. The effects and molecular mechanism of heat stress on spermatogenesis and the mitigation measures. Syst Biol Reprod Med. (2022) 68:331–47. doi: 10.1080/19396368.2022.2074325

PubMed Abstract | Crossref Full Text | Google Scholar

7. Chu H, Deng Q-F, and Fang Y. Vitamin D protects spermatogonia and sertoli cells from heat stress damage by inhibiting NLRP3. Front Pediatr. (2025) 12:1495310. doi: 10.3389/fped.2024.1495310

PubMed Abstract | Crossref Full Text | Google Scholar

8. Aldahhan RA and Stanton PG. Heat stress response of somatic cells in the testis. Mol Cell Endocrinol. (2021) 527:111216. doi: 10.1016/j.mce.2021.111216

PubMed Abstract | Crossref Full Text | Google Scholar

9. Boisen K, Kaleva M, Main K, Virtanen H, Haavisto A-M, Schmidt I, et al. Difference in prevalence of congenital cryptorchidism in infants between two nordic countries. Lancet. (2004) 363:1264–9. doi: 10.1016/s0140-6736(04)15998-9

PubMed Abstract | Crossref Full Text | Google Scholar

10. Van Brakel J, Kranse R, De Muinck Keizer-Schrama SMPF, Hendriks AEJ, De Jong FH, Bangma CH, et al. Fertility potential in men with a history of congenital undescended testes: a long-term follow-up study. Andrology. (2013) 1:100–8. doi: 10.1111/j.2047-2927.2012.00024.x

PubMed Abstract | Crossref Full Text | Google Scholar

11. Chua ME, Mendoza JS, Gaston MJV, Luna SL, and Morales ML. Hormonal therapy using gonadotropin releasing hormone for improvement of fertility index among children with cryptorchidism: a meta-analysis and systematic review. J Pediatr Surg. (2014) 49:1659–67. doi: 10.1016/j.jpedsurg.2014.06.013

PubMed Abstract | Crossref Full Text | Google Scholar

12. Bettencourt MC, Morris ER, Spevak M, and Costabile R. The effect of human chorionic gonadotropin on methotrexate concentration in the rat testes. J Urol. (1997) 158:1581–4. doi: 10.1016/S0022-5347(01)64283-6

PubMed Abstract | Crossref Full Text | Google Scholar

13. Heiskanen P, Billig H, Toppari J, Kaleva M, Arsalo A, Rapola J, et al. Apoptotic cell death in the normal and cryptorchid human testis: The effect of human chorionic gonadotropin on testicular cell survival. Pediatr Res. (1996) 40(2):351–6.

PubMed Abstract | Google Scholar

14. Zhou SH, Deng YF, Weng ZW, Weng HW, and Liu ZD. Traditional Chinese Medicine as a remedy for Male infertility: a review. World J Men’s Health. (2019) 37:175. doi: 10.5534/wjmh.180069

PubMed Abstract | Crossref Full Text | Google Scholar

15. Zhu Y, Zhang J, Liu Q, Xin X, Dong L, Wang B, et al. Semen cuscutae-fructus lycii attenuates tripterygium glycosides-induced spermatogenesis dysfunction by inhibiting oxidative stress-mediated ferroptosis via the Nrf2/HO-1 pathway. Phytomedicine. (2024) 135:156221. doi: 10.1016/j.phymed.2024.156221

PubMed Abstract | Crossref Full Text | Google Scholar

16. Xu X, Qu Z, Qian H, Li Z, Sun X, Zhao X, et al. Ginsenoside Rg1 ameliorates reproductive function injury in C57BL/6J mice induced by di-N-butyl-phthalate. Environ Toxicol. (2021) 36:789–99. doi: 10.1002/tox.23081

PubMed Abstract | Crossref Full Text | Google Scholar

17. Zhao H, Mei J, Huang Q, Wang H, and Xu Z. Research progress of main components from epimedii folium (yinyanghuo) in the treatment of Male reproductive dysfunction and application & development status of epimedii folium. J Ethnopharmacol. (2025) 340:119161. doi: 10.1016/j.jep.2024.119161

PubMed Abstract | Crossref Full Text | Google Scholar

18. Nan Y, Zhang X, Yang G, Xie J, Lu Z, Wang W, et al. Icariin stimulates the proliferation of rat Sertoli cells in an ERK1/2-dependent manner in vitro. Andrologia. (2014) 46:9–16. doi: 10.1111/and.12035

PubMed Abstract | Crossref Full Text | Google Scholar

19. Mäkelä JA, Koskenniemi JJ, Virtanen HE, and Toppari J. Testis development. Endocr. Rev. (2019) 40:857–905. doi: 10.1210/er.2018-00140

PubMed Abstract | Crossref Full Text | Google Scholar

20. Rodprasert W, Virtanen HE, and Toppari J. Cryptorchidism and puberty. Front Endocrinol. (2024) 15:1347435. doi: 10.3389/fendo.2024.1347435

PubMed Abstract | Crossref Full Text | Google Scholar

21. Alumeti Munyali D, Tetsatsi Momo AC, Bonsou Fozin GR, Deeh Defo PB, Petnga Tchatat Y, Lieunang B, et al. Rubus apetalus (rosaceae) improves spermatozoa characteristics, antioxidant enzymes and fertility potential in unilateral cryptorchid rats. Basic Clin Androl. (2020) 30:8. doi: 10.1186/s12610-020-00107-3

PubMed Abstract | Crossref Full Text | Google Scholar

22. Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. (2021) 53:1712–21. doi: 10.1038/s41588-021-00978-w

PubMed Abstract | Crossref Full Text | Google Scholar

23. Kato T, Mizuno K, Nishio H, Moritoki Y, Kamisawa H, Kurokawa S, et al. Disorganization of claudin-11 and dysfunction of the blood-testis barrier during puberty in a cryptorchid rat model. Andrology. (2020) 8:1398–408. doi: 10.1111/andr.12788

PubMed Abstract | Crossref Full Text | Google Scholar

24. Liu Y and Li X. Molecular basis of cryptorchidism-induced infertility. Sci China Life Sci. (2010) 53:1274–83. doi: 10.1007/s11427-010-4072-7

PubMed Abstract | Crossref Full Text | Google Scholar

25. Cheng Y, Yang Z, Shi J, Yang J, Zhao J, He Y, et al. Total flavonoids of epimedium ameliorates testicular damage in streptozotocin-induced diabetic rats by suppressing inflammation and oxidative stress. Environ Toxicol. (2020) 35:268–76. doi: 10.1002/tox.22864

PubMed Abstract | Crossref Full Text | Google Scholar

26. Lu CS, Wu CY, Wang YH, Hu QQ, Sun RY, Pan MJ, et al. The protective effects of icariin against testicular dysfunction in type 1 diabetic mice via AMPK-mediated Nrf2 activation and NF-κB p65 inhibition. Phytomedicine. (2024) 123:155217. doi: 10.1016/j.phymed.2023.155217

PubMed Abstract | Crossref Full Text | Google Scholar

27. Shaukat A, Shaukat I, Rajput SA, Shukat R, Hanif S, Huang S, et al. Icariin alleviates escherichia coli lipopolysaccharide-mediated endometritis in mice by inhibiting inflammation and oxidative stress. Int J Mol Sci. (2022) 23:10219. doi: 10.3390/ijms231810219

PubMed Abstract | Crossref Full Text | Google Scholar

28. An R, Li B, You L, and Wang X. Improvement of kidney yang syndrome by icariin through regulating hypothalamus-pituitary-adrenal axis. Chin J Integr Med. (2015) 21:765–71. doi: 10.1007/s11655-015-2063-z

PubMed Abstract | Crossref Full Text | Google Scholar

29. Zhang Y, Wu X, Zhu K, Liu S, Yang Y, Yuan D, et al. Icariin attenuates perfluorooctane sulfonate-induced testicular toxicity by alleviating sertoli cell injury and downregulating the p38MAPK/MMP9 pathway. Food Funct. (2022) 13:3674–89. doi: 10.1039/d1fo04135e

PubMed Abstract | Crossref Full Text | Google Scholar

30. Liu DL, Liu SJ, Hu SQ, Chen YC, and Guo J. Probing the potential mechanism of quercetin and kaempferol against heat stress-induced sertoli cell injury: Through integrating network pharmacology and experimental validation. IJMS. (2022) 23:11163. doi: 10.3390/ijms231911163

PubMed Abstract | Crossref Full Text | Google Scholar

31. Ma B, Zhang J, Zhu Z, Zhao A, Zhou Y, Ying H, et al. Luteolin ameliorates testis injury and blood–testis barrier disruption through the Nrf2 signaling pathway and by upregulating Cx43. Mol Nutr Food Res. (2019) 63:1800843. doi: 10.1002/mnfr.201800843

PubMed Abstract | Crossref Full Text | Google Scholar

32. Liu SP, Li Y, Zhang D, Li C, Dai X, Lan DF, et al. Pharmacological actions of the bioactive compounds of epimedium on the Male reproductive system: current status and future perspective. Asian J Androl. (2025) 27:20–9. doi: 10.4103/aja20248

PubMed Abstract | Crossref Full Text | Google Scholar

33. Xu Y, Lei H, Guan R, Gao Z, Li H, Wang L, et al. Prophylactic protective effects and its potential mechanisms of IcarisideII on streptozotocin induced spermatogenic dysfunction. Int J Mol Sci. (2014) 15:16100–13. doi: 10.3390/ijms150916100

PubMed Abstract | Crossref Full Text | Google Scholar

34. Behairy A, Hashem MM, Abo-El-Sooud K, El-Metwally AE, Hassan BA, and Abd-Elhakim YM. Quercetin abates aluminum trioxide nanoparticles and lead acetate induced altered sperm quality, testicular oxidative damage, and sexual hormones disruption in Male rats. Antioxidants. (2022) 11:2133. doi: 10.3390/antiox11112133

PubMed Abstract | Crossref Full Text | Google Scholar

35. Ajisebiola BS, Toromade AA, Oladele JO, Mustapha A-RK, Fagbenro OS, and Adeyi AO. Echis ocellatus venom-induced sperm functional deficits, pro-apoptotic and inflammatory activities in Male reproductive organs in rats: antagonistic role of kaempferol. BMC Pharmacol Toxicol. (2024) 25:46. doi: 10.1186/s40360-024-00776-0

PubMed Abstract | Crossref Full Text | Google Scholar

36. Santos-Ahmed J, Brown C, Smith SD, Weston P, Rasoulpour T, Gilbert ME, et al. Akt1 protects against germ cell apoptosis in the postnatal mouse testis following lactational exposure to 6-N-propylthiouracil. Reprod Toxicol. (2011) 31:17–25. doi: 10.1016/j.reprotox.2010.09.012

PubMed Abstract | Crossref Full Text | Google Scholar

37. Chen BF, Suen YK, Gu S, Li L, and Chan WY. A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor. Sci Rep. (2014) 4:6413. doi: 10.1038/srep06413

PubMed Abstract | Crossref Full Text | Google Scholar

38. Sanmamed MF, Esteban E, Uriol E, Zarate R, Capelan M, Muriel C, et al. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours. J Transl Med. (2017) 15:62. doi: 10.1186/s12967-017-1162-3

PubMed Abstract | Crossref Full Text | Google Scholar

39. Thacharodi A, Hassan S, Acharya G, Vithlani A, Hoang Le Q, and Pugazhendhi A. Endocrine disrupting chemicals and their effects on the reproductive health in men. Environ Res. (2023) 236:116825. doi: 10.1016/j.envres.2023.116825

PubMed Abstract | Crossref Full Text | Google Scholar

40. Yamagishi S, Maeda S, Matsui T, Ueda S, Fukami K, and Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochimica et Biophysica Acta (BBA) - General Subjects (2012) 1820(5):663–71.

Google Scholar

41. Xiao L, Wang Z, Lu N, Wei H, Kang J, Yuan M, et al. Dihydrotestosterone through blockade of TGF-β/smad signaling mediates the anti-fibrosis effect under hypoxia in canine sertoli cells. J Steroid Biochem Mol Biol. (2022) 216:106041. doi: 10.1016/j.jsbmb.2021.106041

PubMed Abstract | Crossref Full Text | Google Scholar

42. Wei H, Xiao L, Yao H, Li X, Wang W, Lee Y, et al. Melatonin through blockade of hif-1α signaling mediates the anti-fibrosis under hypoxia in canine sertoli cells. Reprod Biol. (2022) 22:100677. doi: 10.1016/j.repbio.2022.100677

PubMed Abstract | Crossref Full Text | Google Scholar

43. Ray Chaudhuri A and Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. (2017) 18:610–21. doi: 10.1038/nrm.2017.53

PubMed Abstract | Crossref Full Text | Google Scholar

44. Alkhatib HM, Chen DF, Cherney B, Bhatia K, Notario V, Giri C, et al. Cloning and expression of cDNA for human poly(ADP-ribose) polymerase. Proc Natl Acad Sci. (1987) 84:1224–8. doi: 10.1073/pnas.84.5.1224

PubMed Abstract | Crossref Full Text | Google Scholar

45. Liu Y, Long H, Sun Q, Zhang D, Zheng J, and Zhang H. External pressure induced the dysfunction of sertoli cells via the fas/FasL signaling pathway. Syst Biol Reprod Med. (2024) 70:289–98. doi: 10.1080/19396368.2024.2403383

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: Undescended Testis, Epimedium, network pharmacology, Mendelian randomization, Traditional Chinese Medicine

Citation: Deng Z, Zhang S, Zhao H, Xu S, Qi M, Pu T and Wang H (2025) Exploration of the active components and mechanisms of Epimedium for the treatment of Undescended Testis. Front. Endocrinol. 16:1642197. doi: 10.3389/fendo.2025.1642197

Received: 06 June 2025; Accepted: 05 August 2025;
Published: 27 August 2025.

Edited by:

Katja Teerds, Wageningen University and Research, Netherlands

Reviewed by:

Vivek P. Chavda, L M College of Pharmacy, India
Dongfang Lv, Shandong University of Traditional Chinese Medicine, China

Copyright © 2025 Deng, Zhang, Zhao, Xu, Qi, Pu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hui Wang, YW5uaWV3YW5nQG5qbXUuZWR1LmNu

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.